S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
S&P 500   3,951.57 (+0.89%)
DOW   32,244.58 (+1.20%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
NASDAQ:AXSM

Axsome Therapeutics - AXSM Earnings Date, Estimates & Call Transcripts

$63.20
+0.46 (+0.73%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$60.65
▼
$63.62
50-Day Range
$58.39
▼
$75.00
52-Week Range
$20.63
▼
$82.00
Volume
675,028 shs
Average Volume
998,103 shs
Market Capitalization
$2.75 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$104.64

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 27)
-$1.28 Missed By -$0.10
Consensus EPS
(Feb. 27)
-$1.18
Last Year's Q1 EPS
(3/1/2022)
-$0.90
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AXSM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AXSM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Axsome Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20235($1.39)($1.15)($1.32)
Q2 20235($1.40)($1.22)($1.28)
Q3 20235($1.30)($1.01)($1.14)
Q4 20235($1.26)($0.82)($1.04)
FY 202320($5.35)($4.20)($4.79)
Q1 20243($1.21)($0.25)($0.85)
Q2 20243($1.58)$1.30($0.51)
Q3 20243($1.53)$2.73$0.02
Q4 20243($1.09)$3.79$0.64
FY 202412($5.41)$7.57($0.70)

AXSM Earnings Date and Information

Axsome Therapeutics last issued its earnings results on February 27th, 2023. The reported ($1.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.18) by $0.10. The firm earned $24.37 million during the quarter, compared to analysts' expectations of $21.51 million. Axsome Therapeutics has generated ($4.57) earnings per share over the last year (($4.57) diluted earnings per share). Earnings for Axsome Therapeutics are expected to grow in the coming year, from ($4.52) to ($0.92) per share. Axsome Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 1st, 2023 based off prior year's report dates.

Axsome Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2023
(Estimated)		        
2/27/2023Q4 2022($1.18)($1.28)($0.10)($1.15)$21.51 million$24.37 million    
11/7/2022Q3 2022($1.10)($1.03)+$0.07($0.99)$16.59 million$16.85 million
8/9/2022Q2 2022($1.19)($1.06)+$0.13($1.06)$9.59 million$8.82 million    
5/2/2022Q1 2022($1.02)($1.03)($0.01)($1.03)    
3/1/2022Q4 2021($0.99)($0.90)+$0.09($0.90)    
11/8/20219/30/2021($0.95)($0.93)+$0.02($0.93)    
8/8/20216/30/2021($0.88)($0.86)+$0.02($0.86)    
5/9/20213/31/2021($0.83)($0.78)+$0.05($0.78)  
2/28/202112/31/2020($0.73)($0.78)($0.05)($0.78)  
11/10/20209/30/2020($0.57)($0.58)($0.01)($0.55)  
8/10/20206/30/2020($0.54)($0.49)+$0.05($0.49)  
5/8/20203/31/2020($0.60)($0.88)($0.28)($0.88)  
3/12/202012/31/2019($0.48)($0.71)($0.23)($0.71)  
11/7/2019Q3($0.41)($0.56)($0.15)($0.56)  
8/8/2019Q2 2019($0.31)($0.41)($0.10)($0.41)
5/9/20193/31/2019($0.31)($0.32)($0.01)($0.32)  
3/14/201912/31/2018($0.33)($0.32)+$0.01($0.32)
11/9/20189/30/2018($0.33)($0.31)+$0.02($0.31)
8/8/2018Q2 2018($0.32)($0.32)($0.32)
5/8/2018Q1 2018($0.28)($0.19)+$0.09($0.19)  
3/7/2018Q4 2017($0.32)($0.28)+$0.04($0.25)  
11/8/2017Q3 2017($0.27)($0.27)($0.27)
8/9/2017Q2 2017($0.31)($0.30)+$0.01($0.30)
5/9/20173/31/2017($0.40)($0.41)($0.01)($0.41)
3/7/2017Q4 2016($0.38)($0.38)($0.38)
11/14/2016Q3($0.39)($0.38)+$0.01($0.38)
8/9/2016Q2 2016($0.39)($0.36)+$0.03($0.36)
5/11/2016Q116($0.28)($0.31)($0.03)($0.31)
3/24/2016Q416($0.22)($0.12)+$0.10($0.12)












Axsome Therapeutics Earnings - Frequently Asked Questions

When is Axsome Therapeutics's earnings date?

Axsome Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 1st, 2023 based off last year's report dates. Learn more on AXSM's earnings history.

Did Axsome Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Axsome Therapeutics (NASDAQ:AXSM) missed the analysts' consensus estimate of ($1.18) by $0.10 with a reported earnings per share (EPS) of ($1.28). Learn more on analysts' earnings estimate vs. AXSM's actual earnings.

How can I listen to Axsome Therapeutics's earnings conference call?

The conference call for Axsome Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Axsome Therapeutics's conference call transcript?

The conference call transcript for Axsome Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Axsome Therapeutics generate each year?

Axsome Therapeutics (NASDAQ:AXSM) has a recorded annual revenue of $50.04 million.

How much profit does Axsome Therapeutics generate each year?

Axsome Therapeutics (NASDAQ:AXSM) has a recorded net income of -$187.13 million. AXSM has generated -$4.57 earnings per share over the last four quarters.

What is Axsome Therapeutics's EPS forecast for next year?

Axsome Therapeutics's earnings are expected to grow from ($4.52) per share to ($0.92) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:AXSM) was last updated on 3/20/2023 by MarketBeat.com Staff